Agalsidase beta treatment is associated with improved quality of life in patients with Fabry disease: Findings from the Fabry Registry

Torquil Watt, Alessandro P Burlina, Chiara Cazzorla, Dorothee Schönfeld, Maryam Banikazemi, Robert J Hopkin, Ana Maria Martins, Katherine Sims, Dana Beitner-Johnson, Fanny O'brien, Ulla Feldt-Rasmussen
  • Genetics in Medicine, September 2010, Springer Science + Business Media
  • DOI: 10.1097/gim.0b013e3181f13a4a

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Professor Ulla Feldt-Rasmussen